Regulus Therapeutics
RGLS
#6949
Rank
HK$4.39 B
Marketcap
HK$63.52
Share price
0.00%
Change (1 day)
437.05%
Change (1 year)

Earnings for Regulus Therapeutics (RGLS)

Earnings in 2025 (TTM): -HK$0.37 Billion

According to Regulus Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -HK$0.36 Billion a decrease over its 2023 earnings that were of -HK$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regulus Therapeutics from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$0.37 Billion2.6%
2024 -HK$0.36 Billion56.97%
2023 -HK$0.23 Billion6.51%
2022 -HK$0.22 Billion2.53%
2021 -HK$0.21 Billion93.59%
2020 -HK$0.11 Billion-15.41%
2019 -HK$0.13 Billion-64.46%
2018 -HK$0.37 Billion-33.26%
2017 -HK$0.55 Billion-13.98%
2016 -HK$0.63 Billion44.77%
2015 -HK$0.44 Billion-1.63%
2014 -HK$0.45 Billion203.6%
2013 -HK$0.15 Billion8.65%
2012 -HK$0.14 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
GlaxoSmithKline
GSK
HK$72.57 B-19,756.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
HK$70.84 B-19,287.12%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
HK$14.82 B-4,114.42%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$101.90 B-27,699.15%๐Ÿ‡ฌ๐Ÿ‡ง UK
Alnylam Pharmaceuticals
ALNY
HK$1.01 B-374.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-HK$0.85 Billion 129.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$62.53 B-17,036.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-HK$0.92 Billion 148.06%๐Ÿ‡บ๐Ÿ‡ธ USA